Skip to main content
Journal Article

Immunotherapy targeting WT1: Designing a protocol for WT1 peptide-based cancer vaccine

Methods in Molecular Biology (2016) 1467 221-232
DOI: 10.1007/978-1-4939-4023-3_19
4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

There is much current excitement about the potential of cancer immunotherapy. WT1 is high on the National Cancer Institute’s list of priority antigens for immune therapy. In this chapter we describe a protocol for a clinical trial using a WT1 peptide-based cancer vaccine.

Author supplied keywords

Cite

CITATION STYLE

APA

Nishida, S., & Sugiyama, H. (2016). Immunotherapy targeting WT1: Designing a protocol for WT1 peptide-based cancer vaccine. Methods in Molecular Biology, 1467, 221–232. https://doi.org/10.1007/978-1-4939-4023-3_19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free